On follow-up, we observed a partial resolution of the hemolysis pattern: no schistocyte was found, LDH levels showed a decreasing trend, and anemia and thrombocytopenia were no longer observed.
← all excerpts
Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report.
1
—
—